0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Paeoniflorin Improves Cardiac Function and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Rat Model of Acute Myocardial Infarction [Corrigendum]

      Drug Design, Development and Therapy

      Dove

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chen H, Dong Y, He X, Li J, Wang J. Drug Des Devel Ther. 2018;12:823–836. The authors have advised Figure 11D on page 833 is incorrect. Due to an error at the time of figure assembly Figure 10D and Figure 11D were duplicated. The correct Figure 11 is shown below. Figure 11 Effect of the PF on the expression of Caspase-9 in rats with myocardial infarction (immunohistochemistry, ×200). Note: (A) Sham-operated control, (B) model control, (C) captopril group, (D) low-dose group, (E) middle dose group and (F) high-dose group. Abbreviation: PF, paeoniflorin. The authors apologize for this error and advise it does not affect the results of the paper.

          Related collections

          Author and article information

          Journal
          Drug Des Devel Ther
          Drug Des Devel Ther
          dddt
          dddt
          Drug Design, Development and Therapy
          Dove
          1177-8881
          18 November 2020
          2020
          18 November 2020
          : 14
          : 5043
          Article
          291590
          10.2147/DDDT.S291590
          7684998
          © 2020 Chen et al.

          This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

          Page count
          Figures: 0, Pages: 1
          Categories
          Corrigendum

          Pharmacology & Pharmaceutical medicine

          Comments

          Comment on this article